Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7865772rdf:typepubmed:Citationlld:pubmed
pubmed-article:7865772lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7865772lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7865772lifeskim:mentionsumls-concept:C0010132lld:lifeskim
pubmed-article:7865772lifeskim:mentionsumls-concept:C0040616lld:lifeskim
pubmed-article:7865772lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7865772lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7865772pubmed:issue16lld:pubmed
pubmed-article:7865772pubmed:dateCreated1995-3-30lld:pubmed
pubmed-article:7865772pubmed:abstractTextAntisense oligodeoxynucleotide complementary to the start coding region of rat corticotropin releasing hormone (CRH) mRNA was intracerebroventricularly infused into rats three times at 12-h intervals. In the shuttle-box avoidance procedure antisense-treated rats showed, within 6 h, significant acceleration and increase in the total number of discriminative avoidance responses compared with controls, treated with the corresponding sense probe or vehicle alone. Following the shuttle-box experiment hypothalamic CRH hybridization signals and immunoreactivity were reduced, while CRH immunoreactivity in the median eminence remained unchanged. Plasma ACTH and corticosterone were decreased in antisense-treated animals. It is likely that in addition to a selective blockade of CRH translation, antisense treatment may also interrupt secretion of CRH. Antisense targeting of the hypothalamo-hypophysial-adrenal axis may provide new strategies for the neuropharmacology of affective disorders.lld:pubmed
pubmed-article:7865772pubmed:languageenglld:pubmed
pubmed-article:7865772pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7865772pubmed:citationSubsetIMlld:pubmed
pubmed-article:7865772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7865772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7865772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7865772pubmed:statusMEDLINElld:pubmed
pubmed-article:7865772pubmed:monthOctlld:pubmed
pubmed-article:7865772pubmed:issn0959-4965lld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:BreeseG RGRlld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:HolsboerFFlld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:MokMMlld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:CriswellHHlld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:JirikowskiG...lld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:ProbstJ CJClld:pubmed
pubmed-article:7865772pubmed:authorpubmed-author:SkutellaTTlld:pubmed
pubmed-article:7865772pubmed:issnTypePrintlld:pubmed
pubmed-article:7865772pubmed:day27lld:pubmed
pubmed-article:7865772pubmed:volume5lld:pubmed
pubmed-article:7865772pubmed:ownerNLMlld:pubmed
pubmed-article:7865772pubmed:authorsCompleteYlld:pubmed
pubmed-article:7865772pubmed:pagination2181-5lld:pubmed
pubmed-article:7865772pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:meshHeadingpubmed-meshheading:7865772-...lld:pubmed
pubmed-article:7865772pubmed:year1994lld:pubmed
pubmed-article:7865772pubmed:articleTitleCorticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat.lld:pubmed
pubmed-article:7865772pubmed:affiliationMax Planck Institute of Psychiatry, Clinical Institute, Munich, Germany.lld:pubmed
pubmed-article:7865772pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7865772pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed